13 /100
LOW RISK
Score updated May 29, 2026

APLS — Apellis Pharmaceuticals, Inc. Dilution Risk Tracker

Track APLS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track APLS — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for APLS.
🔔 Track APLS — Get forecast alerts →

💹 Market Data

Market Cap$5.25B
Shares Outstanding128.02M
Float83.22M
Cash$406.20M
Debt$475.76M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 0.4% shares (2025Q4 vs prior)
287 institutional holders · 134.28M shares
#1 WELLINGTON MANAGEMENT GROUP LLP 12.72M shares
#2 Avoro Capital Advisors LLC 12.22M shares
#3 VANGUARD GROUP INC 10.67M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest10.75M
Days to Cover3.1
% of Float12.9%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2022
xbrl XBRL WARRANT Dec 31, 2018
4 INSIDER TRANSACTION May 01, 2026
4 INSIDER TRANSACTION Apr 20, 2026
4 INSIDER TRANSACTION Apr 08, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track APLS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking APLS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for APLS
📊 APLS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 APLS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.